In May 2024, GSK announced positive headline results from the phase III clinical trials SWIFT-1 and SWIFT-2, which assessed the efficacy and safety of depemokimab versus placebo in adults and ...

From visits to the emergency ward by the elderly due to breathing difficulties to a sudden spike in the number of patients affected by COPD (chronic obstructive pulmonary disease ... “Even patients ...

Analyst Ram Selvaraju of H.C. Wainwright reiterated a Buy rating on Verona Pharma (VRNA – Research Report), boosting the price target to ...

Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”) announces that senior management will present a company ...

A new study reveals that ensifentrine, a novel COPD treatment, significantly reduces COPD-related healthcare usage over 48 ...

Q3 2024 Earnings Conference Call November 4, 2024 9:00 AM ETCompany ParticipantsDavid Zaccardelli - President and ...

As reported by the Central Pollution Control Board's SAMEER app, Mumbai's Air Quality Index (AQI) on Sunday was 157, which ...

Ohtuvayre™ (ensifentrine) launch recorded Q3 net sales of $5.6 million and October net sales exceeded Q3 Through October more ...

Do cough, cold or other respiratory issues disrupt your sleep in the rising air pollution? Explore the best nebulizer ...

There is no cure for COPD, but it can be managed and treated by working with your healthcare team to develop a plan to keep your COPD under control. Along with quitting smoking, staying up to date ...

David Lynch reveals emphysema diagnosis due to smoking, but remains optimistic, stating he's "filled with happiness" with no ...

After Diwali celebrations, the air quality in Gurgaon has significantly deteriorated, leading to a sharp rise in respiratory ...